Bedikian AY, Del Vecchio M. Allovectin-7 therapy in metastatic melanoma.
Expert Opin Biol Ther 2008;
8:839-44. [PMID:
18476795 DOI:
10.1517/14712598.8.6.839]
[Citation(s) in RCA: 29] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
BACKGROUND
Patients with metastatic melanoma are immunosuppressed by the growing tumor. Allovectin-7 therapy is a form of active immunotherapy that aims at immunization of the host with substances designed to elicit an immune reaction that will eliminate or slow down the growth and spread of the cancer.
OBJECTIVE
to describe the rationale for immunotherapy with Allovectin-7 and assess its safety profile and efficacy based on the results of completed melanoma clinical trials.
METHODS
we reviewed both the published medical literature and the results of trials pending publication.
RESULTS/CONCLUSION
Allovectin-7 is a safe and active immunotherapeutic agent. It induces local and systemic durable responses in patients with metastatic melanoma.
Collapse